If you think you may qualify for one of these studies, please contact Neurology Research Partners at (303) 724-4644 or NeurologyResearchPartners@ucdenver.edu for more information.
|COMIRB #||Title (Please click on the title to see approved advertisement)||Principal Investigator||Eligibility and Information||Advertisement|
|17-2136||Phase 2 Study of Allogenic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke – CoBIS 2||William Jones, MD||Clinical Trials||N/A|
|17-2334||AMPLATZERTM PFO Occluder Post Approval Study||Karen Orjuela, MD||Clinical Trials||N/A|
|19-0675||Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema following Large Hemispheric Infarction (CHARM)||Sharon Poisson, MD||Clinical Trials||N/A|